Related Experiment Video
Updated: Jun 9, 2026
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion
Prabhjeet Kaur1, Praveena Dhiman, Neeraj Dhawan
1Department of Pediatrics, Government Multi Speciality Hospital, Sector 16, Chandigarh- 160 015, India.
Background:
The appropriate duration of albendazole therapy in neurocysticercosis is uncertain. The observation in small uncontrolled randomized trials in children that short-course therapy (1 week) is as effective as the conventional regimen (4weeks) must be tested.
Objective:
To compare the efficacy of 1 and 4 weeks of albendazole therapy in children with single small enhancing computed tomographic lesion (SSECTL).
Study Design:
An open-labeled, randomized, clinical trial.
Materials And Methods:
One hundred twenty children with SSECTLs presenting with seizure.
Intervention:
The subjects were assigned to two groups using random tables: group A (n=58) received albendazole for 1 week and group B (n=62) for 4 weeks. All the subjects were followed up for 6 months.
Results:
The proportions of subjects with complete resolution of lesion in the two groups were similar (group A 63.8% versus group B 51.6%). The proportion of subjects in the two groups in whom the lesion calcified on follow up (group A 19% versus group B 24.2%) also did not differ significantly. The incidence of seizure recurrence during the 6-month follow-up period was also similar in both the groups (group A 9.6% versus group B 3.4%, P > 0.05).
Conclusion:
One week of albendazole therapy is as effective as 4 weeks of therapy in children with SSECTLs.
